Lonza : Announces Results of the 2021 Annual General Meeting – All Motions Proposed by Board of Directors Accepted
May 06, 2021 at 07:01 am EDT
Share
Lonza Announces Results of the 2021 Annual General Meeting - All Motions Proposed by Board of Directors Accepted
47,080,080 shareholders delegated their votes to the independent proxy, representing 63.22% of the share capital
Shareholders re-elected all existing members of the Board of Directors
Albert M. Baehny was re-elected as Chairman of the Board of Directors for another year
A dividend of CHF 3.00 per share will be paid out starting from 12 May 2021
Basel, Switzerland, 6 May 2021 - Today, Lonza Group Ltd hosted its Annual General Meeting, led by the Chairman of the Board of Directors, Albert M. Baehny. Due to the ongoing COVID-19 pandemic, no shareholders were admitted to attend the Annual General Meeting in person. Lonza had previously recommended that shareholders delegate their votes to the independent proxy on 25 March 2021. The independent proxy represented 100% of the 47,080,080votes represented at the Annual General Meeting.
The Board members standing for re-election (Albert M. Baehny, Werner Bauer,Dorothée Deuring, Angelica Kohlmann, Christoph Mäder, Barbara Richmond, Jürgen Steinemann and Olivier Verscheure) were all elected for a further term in office of one year.
The Annual General Meeting re-electedAlbert M. Baehnyas Chairman of the Board of Directors for a term in office of one year. The shareholders also re-elected Angelica Kohlmann, Christoph Mäder and Jürgen Steinemann as the three acting members of the Nomination and Compensation Committee.
The shareholders supported all other motions proposed by the Board of Directors, including among others the acceptance of the remuneration report and the binding votes on the compensation for the Board of Directors and the Executive Committee. The shareholders also approved the renewal of the authorized share capital.
A dividend of CHF 3.00 per share, as proposed by the Board of Directors and accepted by the shareholders, will be paid out starting from 12 May 2021.Fifty percent of this dividend will be paid out of the capital contribution reserve and will be free from Swiss withholding tax.
For further information please see the short-form minutes of the 2021 Lonza Annual General Meeting under the followinglink.
News release (PDF) AGM Speeches (PDF) AGM Short Minutes (PDF)
Attachments
Original document
Permalink
Disclaimer
Lonza Group Ltd. published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 11:00:01 UTC.
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:
- bio-pharmaceuticals (52.6%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;
- capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (20.3%). In addition, the group offers nutritional ingredients;
- small molecule drug substances (13.2%);
- technologies and platforms for manufacturing processes and production of cell and gene therapies (11.1%);
- other (2.8%).
Net sales are distributed geographically as follows: Switzerland (16%), Europe (29.8%), the United States (38.8%), the Americas (3%), Japan (3.7%), China (2.6%), Asia (5.8%) and other (0.3%).
LONZA GROUP AG 
